These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34731883)

  • 1. The Donnan-dominated resting state of skeletal muscle fibers contributes to resilience and longevity in dystrophic fibers.
    Morris CE; Wheeler JJ; Joos B
    J Gen Physiol; 2022 Jan; 154(1):. PubMed ID: 34731883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
    Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
    Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres.
    Allard B
    J Muscle Res Cell Motil; 2006; 27(5-7):367-73. PubMed ID: 16874448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of proteases in excitation-contraction coupling failure in muscular dystrophy.
    Mázala DA; Grange RW; Chin ER
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
    Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
    Beekman C; Sipkens JA; Testerink J; Giannakopoulos S; Kreuger D; van Deutekom JC; Campion GV; de Kimpe SJ; Lourbakos A
    PLoS One; 2014; 9(9):e107494. PubMed ID: 25244123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver.
    Hughes MS; Marsh JN; Wallace KD; Donahue TA; Connolly AM; Lanza GM; Wickline SA
    Ultrasound Med Biol; 2007 Aug; 33(8):1236-43. PubMed ID: 17467153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
    Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
    Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory control over Ca(2+) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression.
    Teichmann MD; Wegner FV; Fink RH; Chamberlain JS; Launikonis BS; Martinac B; Friedrich O
    PLoS One; 2008; 3(11):e3644. PubMed ID: 18982068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.
    Péladeau C; Jasmin BJ
    Methods Mol Biol; 2023; 2587():495-510. PubMed ID: 36401046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
    Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
    Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD.
    Creisméas A; Gazaille C; Bourdon A; Lallemand MA; François V; Allais M; Ledevin M; Larcher T; Toumaniantz G; Lafoux A; Huchet C; Anegon I; Adjali O; Le Guiner C; Fraysse B
    J Transl Med; 2021 Dec; 19(1):519. PubMed ID: 34930315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic Swelling of Sick Excitable Cells - Impaired Ion Homeostasis and Membrane Tension Homeostasis in Muscle and Neuron.
    Morris CE
    Curr Top Membr; 2018; 81():457-496. PubMed ID: 30243439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.